Karyopharm Therapeutics, Inc. has entered into a preferred provider agreement with Clinipace Worldwide for the management of several clinical programs for oncology, wound healing, and other diseases. Clinipace will provide services under its digital CRO model aimed at accelerating a personalized approach to targeted therapies through collaboration, higher data quality, and reduced development costs.    “It is our mission to foster scientific creativity with pioneering technologies and developmen...